Abstract
Anti-TRGV9 antibodies or antigen binding fragments thereof are described. Also described are nucleic acids encoding the antibodies, compositions comprising the antibodies, methods of producing the antibodies, and methods of using the antibodies for treating or preventing diseases, such as cancer.
Full Text
What is claimed is:
Anti-TRGV9 antibodies or antigen binding fragments thereof are described. Also described are nucleic acids encoding the antibodies, compositions comprising the antibodies, methods of producing the antibodies, and methods of using the antibodies for treating or preventing diseases, such as cancer.
Timeline
Filed
06/05/2026Published
09/17/2026Granted
Not AvailableIPC Codes(2)
C07K 16/28:against receptors, cell surface antigens or cell surface determinants
A61K 38/17:from animals; from humans